James Liu

James Liu earned his BS in Microbiology from the University of Wisconsin–Madison and an MS in Immunology from the University of Southern California. James initially joined ImmuneBridge to help optimize NK cell differentiation from hematopoietic stem cells. He then continued his work in immuno-oncology at Revolution Medicines, where he investigated the effects of RAS inhibitors on the tumor microenvironment. James is excited to return to ImmuneBridge and continue advancing innovative therapies. MS: University of Southern California.